{
    "symbol": "FEIM",
    "quarter": 3,
    "year": 2022,
    "date": "2022-03-10 22:02:05",
    "content": " Bookings for the fiscal year are solid, running well ahead of where we thought we\u2019d be for the year and up about 30% from this point last year for the New York operation and up about 21% overall for the company. For the nine months ended January 31, 2022 consolidated revenue was $38.1 million, compared to $38.6 million for the same period of the prior fiscal year. Revenues from non-space U.S. Government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments, were $14.9 million compared to $16.3 million in the same period of the prior fiscal year and accounted for approximately 39% of consolidated revenue compared to 42% for the prior fiscal year. R&D expense for the nine months ended January 31, 2022 and 2021 increased to $3.9 million from $3.5 million, an increase of 400,000 and were approximately 10% and 9% of consolidated revenue. For the nine months ended January 31, 2022, the company recorded an operating loss of $2.1 million compared to an operating loss of $1.1 million in the prior year. In the nine-month ended January 31, 2022 investment income included $123,000 dividend from Morion, compared to 105,000 dividend from Morion in the same period at fiscal 2021. For the nine months ended January 31, 2022, the company recorded a tax provision of $3,000 compared to $37,000 for the prior fiscal year. Consolidated net loss for the nine months ended January 31, 2022 was $1.8 million or $0.20 per share compared to $700,000 net loss or $0.08 per share in the previous fiscal year. Our fully funded backlog at the end of January 2022 was approximately $42 million, up $2 million from the previous fiscal year ended April 30, 2021. The company\u2019s balance sheet continues to reflect the strong working capital position of approximately $40 million at January 1, 2022 and a current ratio of approximately 4.8 to 1."
}